FDA Approves Rebyota for Prevention of CDI
The U.S. Food and Drug Administration recently approved Rebyota, the first fecal microbiota product approved by the agency. Rebyota is approved for the prevention of recurrence of Clostridioides difficile infection (CDI) …
FDA Approves Rebyota for Prevention of CDI Read More